ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial

NCT01913483 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

732

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Endovascular Interventions
Bleeding

Interventions

DRUG: Bivalirudin
DRUG: Unfractionated Heparin

Sponsor

The Medicines Company